Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty

Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty

This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.

Inclusion Criteria:

• Patient having signed informed consent
• Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided
• Patients willing to participate in a 5 years follow-up

Exclusion Criteria:

• Active or suspected infection
• Tumor on the concerned knee
• Patient vulnerable and under legal protection